Abstract
Novel minimally invasive mitral valve interventions for dysfunctional mitral bioprosthesis are being performed through the apex of the left ventricle. This Transapical approach is also being developed to replace diseased native mitral valve using new generations of catheter-mounted prosthesis. These
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.